These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1709545)

  • 61. Incidence of hepatitis C in patients with chronic elevations of aminotransferases.
    Salazar AE; Hermogenes PW; Yens DP
    J Am Board Fam Pract; 1996; 9(3):157-61. PubMed ID: 8743227
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.
    Vermunt J; Fraser M; Herbison P; Wiles A; Schlup M; Schultz M
    World J Gastroenterol; 2015 Sep; 21(35):10224-33. PubMed ID: 26401088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anticomplementary activity and the safety of intravenous immunoglobulin.
    Rousell RH; Budinger MD; Keppler DC; Victor R; Minaga T
    Clin Ther; 1989; 11(1):143-50. PubMed ID: 2497981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré Study Group.
    Oomes PG; van der Meché FG; Kleyweg RP
    Neurology; 1996 Jan; 46(1):96-100. PubMed ID: 8559429
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Severe viral hepatitis type B in infancy;
    Dupuy JM; Frommel D; Alagille D
    Lancet; 1975 Jan; 1(7900):191-4. PubMed ID: 47420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aminotransferase levels in relation to short-term use of acetaminophen four grams daily in postoperative cardiothoracic patients in the intensive care unit.
    Ahlers SJ; Van Gulik L; Van Dongen EP; Bruins P; Tibboel D; Knibbe CA
    Anaesth Intensive Care; 2011 Nov; 39(6):1056-63. PubMed ID: 22165358
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
    Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
    Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver enzyme values in injection drug users with chronic hepatitis C.
    Mehta SH; Netski D; Sulkowski MS; Strathdee SA; Vlahov D; Thomas DL
    Dig Liver Dis; 2005 Sep; 37(9):674-80. PubMed ID: 15951255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence against the role of hepatitis C virus in severe liver damage occurring early in the course of acute leukemia in children.
    Locasciulli A; Pontisso P; Cavalletto D; Fraschini D; Uderzo C; Masera G; Alberti A
    Leuk Lymphoma; 1994 Mar; 13(1-2):119-22. PubMed ID: 7517743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and patient acceptability of intravenous immune globulin in 10% maltose.
    Ochs HD; Buckley RH; Pirofsky B; Fischer SH; Rousell RH; Anderson CJ; Wedgwood RJ
    Lancet; 1980 Nov; 2(8205):1158-9. PubMed ID: 6107768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The impact of total parenteral nutrition on liver function tests in patients with cancer.
    Wagman LD; Burt ME; Brennan MF
    Cancer; 1982 Mar; 49(6):1249-57. PubMed ID: 6800631
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency.
    Schiff RI
    Vox Sang; 1985; 49 Suppl 1():15-24. PubMed ID: 2416124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis.
    Knodell RG; Conrad ME; Ginsberg AL; Bell CJ
    Lancet; 1976 Mar; 1(7959):557-61. PubMed ID: 55838
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic non-A, non-B hepatitis.
    Hoofnagle JH; Alter HJ
    Prog Clin Biol Res; 1985; 182():63-9. PubMed ID: 3929263
    [No Abstract]   [Full Text] [Related]  

  • 76. [Attempted classification, course and elements of prognosis of chronic hepatitis. Preliminary results of a study of 100 cases].
    Thomas M; Rosner D; Nusinovici V; Caroli J
    Ann Med Interne (Paris); 1972 Feb; 123(2):107-17. PubMed ID: 4115527
    [No Abstract]   [Full Text] [Related]  

  • 77. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.
    Wood P; Stanworth S; Burton J; Jones A; Peckham DG; Green T; Hyde C; Chapel H;
    Clin Exp Immunol; 2007 Sep; 149(3):410-23. PubMed ID: 17565605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
    Slade HB
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):613-9. PubMed ID: 8556510
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.
    Prohaska W; Wolff C; Schlüter K; Köster-Eiserfunke W; Körner MM; Kleesiek K
    Clin Investig; 1992 Jul; 70(7):573-8. PubMed ID: 1327328
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25.
    Rousell RH; Budinger MD; Pirofsky B; Schiff RI
    Vox Sang; 1991; 60(2):65-8. PubMed ID: 1709545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.